Dave vs. OppFi: Which Fintech Stock Is the Smarter Bet Right Now?

Dave (DAVE) is presented as the stronger fintech growth story, reporting 47% revenue growth and a 235% surge in adjusted EBITDA in the March quarter, with ExtraCash originations up 46% and ARPU rising 29% in Q1 2025; its CashAI underwriting reduced 28-day delinquency 18% YoY and cut provisions to originations from 0.94% to 0.69%, while automating 90% of service tickets. OppFi (OPFI) showed more modest top-line growth (+10.1% YoY) but large adjusted net income improvement (+285.1% in the March quarter), with Model 6 cutting net charge-offs by 700 bps QoQ (1,300 bps YoY) and net originations +16% YoY; auto-approval rose to 79%. Analysts peg 2025 sales at $475.8M and EPS $8.76 for DAVE (two upward revisions in 60 days) versus $578.4M sales and $1.23 EPS for OPFI (no recent revisions); valuation contrast (DAVE ~18.5x forward P/E; OPFI ~8.5x) and Zacks ranks (DAVE #1, OPFI #3) underpin the article's bullish preference for Dave despite a valuation premium.

Analysis

Market structure: Winners are AI-driven fintechs (DAVE, OPFI), data/credit-model vendors and partner banks that can scale small-dollar loans; losers include legacy payday lenders and community banks with weak underwriting tech. DAVE’s subscription revenue (recurring $5/mo) increases pricing power and predictability versus OPFI’s interest-dependent margin profile, shifting investor preference toward margin-stable models during benign credit cycles.

Risk assessment: Key tail risks are regulatory action (CFPB rule or state caps) within 6–18 months, model breakdown/fraud causing >200–300 bps spike in NCOs, or a sudden funding squeeze raising wholesale funding costs 200–400 bps. Immediate (days) impact is earnings-driven volatility, short-term (weeks–months) is re-rating around credit metrics, long-term (quarters–years) depends on sustained loss rates and customer LTV; hidden dependency: OPFI’s reliance on partner banks for capital and DAVE’s dependence on retention (churn >5%/quarter would impair ARPU).

Trade implications: Valuation gap (OPFI ~8.5x forward P/E vs DAVE ~18.5x) creates a relative-value opportunity; if credit metrics remain stable, OPFI can re-rate toward 12–15x. Use size-limited exposure (2–5% position sizing), favor mid-dated options to express asymmetric upside while capping drawdowns; monitor 28/90-day delin and provision/origination ratio (trigger levels: DAVE prov/orig >1.1% or OPFI NCO QoQ widening >200 bps).

Contrarian angles: Consensus may overvalue DAVE’s premium for growth durability — a mild recession could erase its margin advantage quickly — while underestimating OPFI’s earnings leverage if Model 6 credit gains persist. Historical parallels: post-2009 fintech winners still faced regulatory squeezes; unintended consequence of aggressive auto-approval is elevated fraud risk that shows up with multi-quarter lag, so near-term credit improvement may be ephemeral.

Key Decisions for Investors

• Establish a 2–3% long position in DAVE (ticker DAVE) over the next 4–12 weeks to capture ongoing revenue/EBITDA momentum; size to 2% initially and scale to 3% if 28-day delin rate stays ≤ prior quarter or provision/origination remains ≤0.75%.
• Initiate a 3–5% value long in OppFi (OPFI) now to play potential re-rating from 8.5x toward 12–15x forward P/E if net originations and NCO improvements persist for two consecutive quarters; trim or stop-loss at −25% or if NCO increases QoQ by >200 bps.
• Run a dollar-neutral pair trade: long OPFI / short DAVE sized 1:1 for a 6–9 month horizon to capture valuation convergence; close if P/E spread halves or if either reports a QoQ revenue miss >5% or a credit metric shock (90-day delin ↑ >100 bps).
• Use options to cap risk: buy a 6-month DAVE call spread (ATM to ~1.2×ATM) sized to 1–1.5% notional to express upside, and buy a 6–9 month OPFI out-of-the-money call (or outright stock) as the cheaper convexity play; avoid naked short exposure and exit on credit metric triggers (see above).